Lawyers for the Lifecycle of Foods, Dietary Supplements,
Cosmetics, Drugs & Medical Devices

What's Now

Amin Talati Law Firm Announces Name Change; Plans to Continue Expansion in Core Areas

Leading regulatory and intellectual property law firm Amin Talati today announced that effective June 1, 2019, the firm’s name changed to Amin Talati Wasserman LLP, making Ivan Wasserman, who also serves as the firm’s managing MORE >

see all news >

Food & Beverage

We support clients throughout the entire lifecycle of products aimed at improving the population's health and wellness: food and beverages, nutritional supplements, and cosmetics.

MORE

Intellectual Property

Drawing heavily on our IP, patent and trademark expertise, we provide our clients with business advice and strategies that enhance product value and head off future litigation.

MORE

Litigation

We are deeply experienced in FDA and FTC disputes, patent and trademark infringement cases, class actions, breach of contract and unfair competition claims. We are renowned in the area of Paragraph IV litigation, where companies challenge brand name patents so that medications can be marketed in generic forms.

MORE

Drugs & Devices

We provide strategic advice to clients from the inception of their drug and device products with a focus on enhancing product value, gaining regulatory approvals, and ensuring compliance.

MORE
What's New
  • news

    Katie Bond Shares Her Thoughts on How to Back Up Advertising Claims and Avoid Risk

    New Hope Network recently featured an article published by Katie Bond titled, “How to Back Up Advertising Claims and Avoid Risk”. Katie discusses the recent regulatory landscape with respect to advertising law and provides valuable insight into strategies for mitigating risk. To read the full article, please click HERE.

  • news

    Amin Talati Upadhye, LLP Team Wins Again at the ITC in False Advertising Case

    On July 9, 2018, Partners Joseph Cwik and Erin Conway earned a complete victory at the U.S. International Trade Commission (“ITC”) for the firm’s client ECI Pharmaceuticals LLC (“ECI”) when Complainants Valeant Pharmaceuticals North America LLC and Valeant Pharmaceuticals International, Inc. withdrew all allegations in their Amended Complaint against ECI and moved to terminate their […]

  • news

    Three’s Company! Al-Mondihry, Bond and Wasserman In One Article On New FTC Leadership

    ATU DC’s Rend Al-Mondhiry, Katie Bond, and Ivan Wasserman have been featured in a recent article published by Natural Products Insider assessing the potential issues with dietary supplement advertising by the new FTC leadership under the Republican Administration. To read the full article, please click HERE.